(Q38001376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Robert G Prosnitz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Anna L Schwartz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Joseph R Carver

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

8 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

2270-2276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

The influence of comorbidities on overall survival among older women diagnosed with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Noncancer deaths in white adult cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Early breast cancer therapy and cardiovascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Risk factors for doxorubicin-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Developing a cardiology-oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Risk of cardiac dysfunction with trastuzumab in breast cancer patients: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Management of trastuzumab-related cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Effects of hormonal treatment on lipids in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Risk of cardiac death after adjuvant radiotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Cardiac morbidity of adjuvant radiotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Cardiovascular late effects and the ongoing care of adult cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

The detection and treatment of cancer-related functional problems in an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

A prospective surveillance model for rehabilitation for women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

Radiation-induced heart disease: vigilance is still required

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

7 January 2021

Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

7 January 2021

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

7 January 2021

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27462

7 January 2021

Identifiers

DOI

10.1002/CNCR.27462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488701%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference